Communiqués Omnicell, Inc.

Actions

OMCL

US68213N1090

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 20/08/2026			Varia. 5j.	Varia. 1 janv.
35,50 ^USD	-2,55%		-4,39%	-21,63%

14/08	US Physical Therapy nomme Nchacha Etta au poste de directeur financier	MT
30/07	Omnicell, Inc. communique ses prévisions de résultats pour le troisième trimestre 2026 et actualise ses objectifs annuels pour 2026	CI

Communiqués

30/07	EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination	BU
30/07	Omnicell: Q2 Earnings Snapshot	AQ
30/07	Omnicell Announces Second Quarter 2026 Financial Results	BU
13/07	Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026	BU
01/07	Nnamdi Njoku Appointed President of Omnicell	BU
08/06	Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business	BU
02/06	Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026	BU
04/05	Omnicell to Present at the BofA Securities 2026 Healthcare Conference	BU
29/04	Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer	BU
28/04	Omnicell : Investor Presentation	PU
28/04	Omnicell: Q1 Earnings Snapshot	AQ
28/04	Omnicell Announces First Quarter 2026 Financial Results	BU
13/04	Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026	BU
05/02	Omnicell : Investor Presentation	PU
05/02	Omnicell: Q4 Earnings Snapshot	AQ
05/02	Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results	BU
13/01	Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026	BU
08/12	Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management	BU
01/12	Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show	BU
20/11	Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference	BU
13/11	Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies	BU
30/10/25	Omnicell : Investor Presentation – October 2025	PU
30/10/25	Omnicell: Q3 Earnings Snapshot	AQ
30/10/25	Omnicell Announces Third Quarter 2025 Financial Results	BU
07/10/25	Omnicell to Release Third Quarter 2025 Financial Results on October 30 2025	AQ